§ Federal grant opportunity · HR001126S0011
Information Processing Techniques Office Office-Wide
DARPA - Information Processing Technologies Office is accepting applications for Information Processing Techniques Office Office-Wide. The deadline is June 22, 2027 and the published award range is Award amount not published.
Key facts
- Funder
- DARPA - Information Processing Technologies Office
- Application deadline
- June 22, 2027
- Award range
- Award amount not published
- Eligibility
- All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HR001126S0011
Program overview
This Broad Agency Announcement (BAA) seeks revolutionary research ideas for topics not being addressed by ongoing IPTO programs or other published solicitations. Potential proposers are highly encouraged to visit the IPTO technical office page (https://www.darpa.mil/about/offices/ipto) to view current and upcoming IPTO programs and solicitations in order to avoid proposing efforts that duplicate existing activities or that are responsive to other published IPTO solicitations.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from DARPA - Information Processing Technologies Office.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before June 22, 2027, allowing time for registration and validation.
Related grant opportunities
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.